Breaking News Instant updates and real-time market news.

GRPN

Groupon

$1.20 /

+0.11 (+10.09%)

15:19
05/18/20
05/18
15:19
05/18/20
15:19

Groupon options imply 24.9% move in share price post-earnings

Pre-earnings options volume in Groupon is 1.5x normal with calls leading puts 5:1. Implied volatility suggests the market is anticipating a move near 24.9%, or 30c, after results are released. Median move over the past eight quarters is 5.4%.

  • 09

    Jun

GRPN Groupon
$1.20 /

+0.11 (+10.09%)

02/25/20 Ascendiant
Groupon price target lowered to $1.75 from $3.25 at Ascendiant
01/17/20 UBS
Groupon upgraded to Buy from Neutral at UBS
12/23/19 Ascendiant
Groupon price target lowered to $3.25 from $4.25 at Ascendiant
12/17/19
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Initiation
Paya Holdings initiated with a Buy at Canaccord » 06:34
10/29/20
10/29
06:34
10/29/20
06:34
PAYA

Paya Holdings

$10.79 /

-0.385 (-3.45%)

Canaccord analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAYA Paya Holdings
$10.79 /

-0.385 (-3.45%)

PAYA Paya Holdings
$10.79 /

-0.385 (-3.45%)

10/27/20 BTIG
Paya Holdings initiated with a Buy at BTIG
Earnings
Carrier Global reports Q3 adjusted EPS 67c, consensus 46c » 06:34
10/29/20
10/29
06:34
10/29/20
06:34
CARR

Carrier Global

$33.23 /

-0.21 (-0.63%)

Reports Q3 revenue $5B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

10/15/20 Stephens
Carrier Global initiated with an Overweight at Stephens
10/13/20
Fly Intel: Top five analyst initiations
10/13/20 Jefferies
Carrier Global initiated with a Buy at Jefferies
10/07/20 JPMorgan
Carrier Global price target raised to $33 from $28 at JPMorgan
CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

CARR Carrier Global
$33.23 /

-0.21 (-0.63%)

Recommendations
Pinterest price target raised to $66 from $32 at Barclays » 06:33
10/29/20
10/29
06:33
10/29/20
06:33
PINS

Pinterest

$48.76 /

-3.82 (-7.27%)

Barclays analyst Ross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$48.76 /

-3.82 (-7.27%)

PINS Pinterest
$48.76 /

-3.82 (-7.27%)

06:23 Today JPMorgan
Pinterest upgraded to Overweight from Neutral at JPMorgan
06:07 Today JPMorgan
Pinterest upgraded to Overweight from Neutral at JPMorgan
06:06 Today MKM Partners
Pinterest upgraded to Buy from Neutral at MKM Partners
04:56 Today Baird
Pinterest price target raised to $68 from $41 at Baird
PINS Pinterest
$48.76 /

-3.82 (-7.27%)

PINS Pinterest
$48.76 /

-3.82 (-7.27%)

PINS Pinterest
$48.76 /

-3.82 (-7.27%)

PINS Pinterest
$48.76 /

-3.82 (-7.27%)

Upgrade
Eni SpA upgraded to Buy from Hold at Societe Generale » 06:32
10/29/20
10/29
06:32
10/29/20
06:32
E

Eni SpA

$13.69 /

-0.64 (-4.47%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
E Eni SpA
$13.69 /

-0.64 (-4.47%)

E Eni SpA
$13.69 /

-0.64 (-4.47%)

10/07/20 Morgan Stanley
Eni SpA price target lowered to EUR 6 from EUR 7.20 at Morgan Stanley
09/01/20 JPMorgan
Eni SpA price target lowered to EUR 8 from EUR 8.50 at JPMorgan
08/03/20 RBC Capital
Eni SpA price target raised to EUR 8 from EUR 7 at RBC Capital
07/31/20 Morgan Stanley
Eni SpA downgraded to Underweight from Equal Weight at Morgan Stanley
Upgrade
Bed Bath & Beyond upgraded to Equal Weight from Underweight at Morgan Stanley » 06:32
10/29/20
10/29
06:32
10/29/20
06:32
BBBY

Bed Bath & Beyond

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
/

+

BBBY Bed Bath & Beyond
/

+

06:08 Today R5 Capital
Bed Bath & Beyond upgraded to Buy from Hold at R5 Capital
06:05 Today Telsey Advisory
Bed Bath & Beyond upgraded to Outperform from Market Perform at Telsey Advisory
10/21/20 Baird
Bed Bath & Beyond could double again if targets achieved, says Baird
10/14/20 Raymond James
Bed Bath & Beyond price target raised to $26 from $22 at Raymond James
BBBY Bed Bath & Beyond
/

+

BBBY Bed Bath & Beyond
/

+

BBBY Bed Bath & Beyond
/

+

BBBY Bed Bath & Beyond
/

+

Earnings
Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year » 06:32
10/29/20
10/29
06:32
10/29/20
06:32
SNY

Sanofi

$46.19 /

-1.23 (-2.59%)

Reports Q3 revenue EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$46.19 /

-1.23 (-2.59%)

SNY Sanofi
$46.19 /

-1.23 (-2.59%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
SNY Sanofi
$46.19 /

-1.23 (-2.59%)

SNY Sanofi
$46.19 /

-1.23 (-2.59%)

SNY Sanofi
$46.19 /

-1.23 (-2.59%)

Recommendations
Mirati Therapeutics price target raised to $244 from $143 at Barclays » 06:32
10/29/20
10/29
06:32
10/29/20
06:32
MRTX

Mirati Therapeutics

$202.32 /

-7.45 (-3.55%)

Barclays analyst Gena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$202.32 /

-7.45 (-3.55%)

MRTX Mirati Therapeutics
$202.32 /

-7.45 (-3.55%)

06:21 Today Credit Suisse
Mirati Therapeutics reinstated with an Outperform at Credit Suisse
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Oppenheimer
Mirati Therapeutics price target raised to $225 from $190 at Oppenheimer
10/26/20 Goldman Sachs
Mirati Therapeutics price target raised to $267 from $152 at Goldman Sachs
MRTX Mirati Therapeutics
$202.32 /

-7.45 (-3.55%)

  • 28
    Oct
  • 10
    Jan
MRTX Mirati Therapeutics
$202.32 /

-7.45 (-3.55%)

Earnings
Textron reports Q3 adjused EPS 53c, consensus 35c » 06:31
10/29/20
10/29
06:31
10/29/20
06:31
TXT

Textron

$32.14 /

-0.82 (-2.49%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXT Textron
$32.14 /

-0.82 (-2.49%)

TXT Textron
$32.14 /

-0.82 (-2.49%)

10/01/20 Cowen
Textron downgraded to Market Perform from Outperform at Cowen
10/01/20 Cowen
Textron downgraded to Market Perform from Outperform at Cowen
09/08/20 Morgan Stanley
Textron initiated with an Equal Weight at Morgan Stanley
08/17/20 Alembic Global
Textron upgraded to Overweight from Neutral at Alembic Global
TXT Textron
$32.14 /

-0.82 (-2.49%)

TXT Textron
$32.14 /

-0.82 (-2.49%)

TXT Textron
$32.14 /

-0.82 (-2.49%)

Hot Stocks
Lloyds Banking sees NIM 'broadly stable' in Q4 » 06:31
10/29/20
10/29
06:31
10/29/20
06:31
LYG

Lloyds Banking

$1.38 /

-0.045 (-3.17%)

Net interest margin is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

09/18/20 Societe Generale
Lloyds Banking price target lowered to 40 GBp at Societe Generale
08/17/20 Deutsche Bank
Lloyds Banking price target lowered to 32 GBp from 34 GBp at Deutsche Bank
08/04/20 UBS
Lloyds Banking price target lowered to 40 GBp from 45 GBp at UBS
08/04/20 JPMorgan
Lloyds Banking price target lowered to 37 GBp from 45 GBp at JPMorgan
LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

Earnings
Lloyds Banking reports 9 months EPS 0.5p vs. 2.2p last year » 06:30
10/29/20
10/29
06:30
10/29/20
06:30
LYG

Lloyds Banking

$1.38 /

-0.045 (-3.17%)

Reports net income of GBP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

09/18/20 Societe Generale
Lloyds Banking price target lowered to 40 GBp at Societe Generale
08/17/20 Deutsche Bank
Lloyds Banking price target lowered to 32 GBp from 34 GBp at Deutsche Bank
08/04/20 UBS
Lloyds Banking price target lowered to 40 GBp from 45 GBp at UBS
08/04/20 JPMorgan
Lloyds Banking price target lowered to 37 GBp from 45 GBp at JPMorgan
LYG Lloyds Banking
$1.38 /

-0.045 (-3.17%)

Recommendations
Gilead price target lowered to $62 from $67 at Barclays » 06:29
10/29/20
10/29
06:29
10/29/20
06:29
GILD

Gilead

$58.78 /

-1.24 (-2.07%)

Barclays analyst Carter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.78 /

-1.24 (-2.07%)

GILD Gilead
$58.78 /

-1.24 (-2.07%)

10/28/20 UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.78 /

-1.24 (-2.07%)

GILD Gilead
$58.78 /

-1.24 (-2.07%)

GILD Gilead
$58.78 /

-1.24 (-2.07%)

GILD Gilead
$58.78 /

-1.24 (-2.07%)

Hot Stocks
Maxar Technologies awarded $8.5M contract from U.S. Space Force » 06:28
10/29/20
10/29
06:28
10/29/20
06:28
MAXR

Maxar Technologies

$26.27 /

-0.73 (-2.70%)

Maxar Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$26.27 /

-0.73 (-2.70%)

MAXR Maxar Technologies
$26.27 /

-0.73 (-2.70%)

09/29/20 RBC Capital
Maxar Technologies price target raised to $30 from $25 at RBC Capital
08/06/20 TD Securities
Maxar Technologies upgraded to Buy from Speculative Buy at TD Securities
06/24/20 JPMorgan
Maxar Technologies price target raised to $20 from $16 at JPMorgan
01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
MAXR Maxar Technologies
$26.27 /

-0.73 (-2.70%)

MAXR Maxar Technologies
$26.27 /

-0.73 (-2.70%)

MAXR Maxar Technologies
$26.27 /

-0.73 (-2.70%)

Recommendations
Amgen price target lowered to $242 from $250 at Barclays » 06:28
10/29/20
10/29
06:28
10/29/20
06:28
AMGN

Amgen

$216.61 /

-6.78 (-3.04%)

Barclays analyst Carter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

10/28/20 UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

AMGN Amgen
$216.61 /

-6.78 (-3.04%)

Hot Stocks
Royal Dutch Shell announces dividend per share growth by around 4% to 16.65c » 06:27
10/29/20
10/29
06:27
10/29/20
06:27
RDS.A

Royal Dutch Shell

$23.11 /

-1.065 (-4.41%)

, RDS.B

Royal Dutch Shell

$21.80 /

-1.18 (-5.13%)

Shell announced a cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDS.A Royal Dutch Shell
$23.11 /

-1.065 (-4.41%)

RDS.B Royal Dutch Shell
$21.80 /

-1.18 (-5.13%)

RDS.A Royal Dutch Shell
$23.11 /

-1.065 (-4.41%)

10/07/20 Morgan Stanley
Royal Dutch Shell price target lowered to 991 GBp at Morgan Stanley
10/05/20 Panmure Gordon
Royal Dutch Shell downgraded to Sell from Hold at Panmure Gordon
09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/24/20 Scotiabank
Scotiabank starts Shell with 'split' Outperform on B shares, Perform on A shares
RDS.B Royal Dutch Shell
$21.80 /

-1.18 (-5.13%)

09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/24/20 Scotiabank
Scotiabank starts Shell with 'split' Outperform on B shares, Perform on A shares
09/01/20 JPMorgan
Royal Dutch Shell price target lowered to 1,600 GBp from 1,700 GBp at JPMorgan
08/03/20 Berenberg
Royal Dutch Shell price target raised to 1,450 GBp from 1,440 GBp at Berenberg
RDS.A Royal Dutch Shell
$23.11 /

-1.065 (-4.41%)

RDS.B Royal Dutch Shell
$21.80 /

-1.18 (-5.13%)

RDS.A Royal Dutch Shell
$23.11 /

-1.065 (-4.41%)

RDS.B Royal Dutch Shell
$21.80 /

-1.18 (-5.13%)

RDS.A Royal Dutch Shell
$23.11 /

-1.065 (-4.41%)

RDS.B Royal Dutch Shell
$21.80 /

-1.18 (-5.13%)

Hot Stocks
Novocure forms alliance with NYU Grossman School of Medicine » 06:27
10/29/20
10/29
06:27
10/29/20
06:27
NVCR

Novocure

$115.55 /

-4.07 (-3.40%)

Novocure announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$115.55 /

-4.07 (-3.40%)

NVCR Novocure
$115.55 /

-4.07 (-3.40%)

10/05/20 Piper Sandler
Bristol-Myers approval removes some Novocure revenue upside, says Piper Sandler
09/23/20
Fly Intel: Top five analyst initiations
09/23/20 Northland
Novocure initiated with an Outperform at Northland
09/18/20
Fly Intel: Top five analyst downgrades
NVCR Novocure
$115.55 /

-4.07 (-3.40%)

Earnings
Southern Company reports Q3 EPS $1.18, consensus $1.21 » 06:27
10/29/20
10/29
06:27
10/29/20
06:27
SO

Southern Company

$58.37 /

-1.89 (-3.14%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SO Southern Company
$58.37 /

-1.89 (-3.14%)

SO Southern Company
$58.37 /

-1.89 (-3.14%)

10/28/20 Mizuho
Southern Company price target raised to $53 from $48 at Mizuho
09/21/20 Barclays
Southern Company upgraded to Overweight from Equal Weight at Barclays
09/10/20
Fly Intel: Top five analyst downgrades
09/10/20 Mizuho
Southern Company downgraded to Underperform on Vogtle concerns at Mizuho
SO Southern Company
$58.37 /

-1.89 (-3.14%)

SO Southern Company
$58.37 /

-1.89 (-3.14%)

Upgrade
Qualitas upgraded to Equal Weight on balanced risk/reward at Barclays » 06:26
10/29/20
10/29
06:26
10/29/20
06:26
QUCOF

Qualitas

$0.00 /

+ (+0.00%)

Barclays analyst Gilberto…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QUCOF Qualitas
$0.00 /

+ (+0.00%)

05:10 Today Barclays
Qualitas upgraded to Equal Weight from Underweight at Barclays
08/12/20 Barclays
Qualitas downgraded to Underweight from Equal Weight at Barclays
Hot Stocks
BJ's Wholesale expands buy online, pick up in-club service » 06:26
10/29/20
10/29
06:26
10/29/20
06:26
BJ

BJ's Wholesale

$39.37 /

+0.08 (+0.20%)

BJ's Wholesale…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

10/15/20 Jefferies
BJ's Wholesale assumed with a Buy at Jefferies
09/21/20 Goldman Sachs
BJ's Wholesale upgraded to Conviction Buy from Buy at Goldman Sachs
08/25/20 Northcoast
BJ's Wholesale price target raised to $54 from $45 at Northcoast
08/21/20 Loop Capital
BJ's Wholesale price target raised to $50 from $45 at Loop Capital
BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

  • 17
    Jan
BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

BJ BJ's Wholesale
$39.37 /

+0.08 (+0.20%)

Upgrade
Cognizant upgraded to Outperform from Market Perform at Cowen » 06:26
10/29/20
10/29
06:26
10/29/20
06:26
CTSH

Cognizant

$71.05 /

-2.32 (-3.16%)

Cowen analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

06:06 Today Cowen
Cognizant upgraded to Outperform from Market Perform at Cowen
10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

CTSH Cognizant
$71.05 /

-2.32 (-3.16%)

Hot Stocks
AB InBev expects 2H performance to be better than 1H » 06:25
10/29/20
10/29
06:25
10/29/20
06:25
BUD

AB InBev

$53.00 /

-2.24 (-4.06%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

10/15/20
Fly Intel: Pre-market Movers
10/15/20 BofA
AB InBev reinstated with a Neutral at BofA
10/09/20 Morgan Stanley
AB InBev price target raised to EUR 44 from EUR 42 at Morgan Stanley
10/07/20 Jefferies
AB InBev upgraded to Buy from Hold at Jefferies
BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

Hot Stocks
CNH Industrial acquires minority stake in Zasso Group AG » 06:25
10/29/20
10/29
06:25
10/29/20
06:25
CNHI

CNH Industrial

$7.76 /

-0.305 (-3.78%)

CNH Industrial announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNHI CNH Industrial
$7.76 /

-0.305 (-3.78%)

CNHI CNH Industrial
$7.76 /

-0.305 (-3.78%)

09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
08/13/20 JPMorgan
JPMorgan downgrades Deere and Oshkosh amid U.S. Machinery ratings reshuffle
08/13/20 JPMorgan
CNH Industrial upgraded to Overweight from Neutral at JPMorgan
07/23/20 OTR Global
Farm Equipment Manufacturers upgraded to Mixed from Negative at OTR Global
CNHI CNH Industrial
$7.76 /

-0.305 (-3.78%)

CNHI CNH Industrial
$7.76 /

-0.305 (-3.78%)

Hot Stocks
AB InBev to forgo interim 2020 dividend payment » 06:25
10/29/20
10/29
06:25
10/29/20
06:25
BUD

AB InBev

$53.00 /

-2.24 (-4.06%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

10/15/20
Fly Intel: Pre-market Movers
10/15/20 BofA
AB InBev reinstated with a Neutral at BofA
10/09/20 Morgan Stanley
AB InBev price target raised to EUR 44 from EUR 42 at Morgan Stanley
10/07/20 Jefferies
AB InBev upgraded to Buy from Hold at Jefferies
BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

BUD AB InBev
$53.00 /

-2.24 (-4.06%)

Upgrade
Vanda Pharmaceuticals upgraded to Buy from Neutral at Citi » 06:25
10/29/20
10/29
06:25
10/29/20
06:25
VNDA

Vanda Pharmaceuticals

$10.08 /

-0.53 (-5.00%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

06/09/20 Citi
Vanda downgraded to Neutral on FDA dispute at Citi
06/09/20 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Oppenheimer
Vanda Pharmaceuticals downgraded to Underperform at Oppenheimer on Hetlioz risks
VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

VNDA Vanda Pharmaceuticals
$10.08 /

-0.53 (-5.00%)

Earnings
Clarivate Analytics raises FY20 adj. EPS view to 55c-61c from 53c-59c » 06:25
10/29/20
10/29
06:25
10/29/20
06:25
CCC

Clarivate Analytics

$29.95 /

-0.325 (-1.07%)

Consensus 59c. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCC Clarivate Analytics
$29.95 /

-0.325 (-1.07%)

CCC Clarivate Analytics
$29.95 /

-0.325 (-1.07%)

10/15/20 Goldman Sachs
Clarivate Analytics reinstated with a Buy at Goldman Sachs
10/14/20 Morgan Stanley
Clarivate Analytics initiated with an Equal Weight at Morgan Stanley
10/02/20 Barclays
Clarivate Analytics price target raised to $35 from $26 at Barclays
08/04/20 Citi
Clarivate Analytics price target raised to $33 from $28 at Citi
CCC Clarivate Analytics
$29.95 /

-0.325 (-1.07%)

  • 04
    Jun
  • 06
    Feb
  • 05
    Dec
CCC Clarivate Analytics
$29.95 /

-0.325 (-1.07%)

Earnings
Willis Towers Watson reports Q3 adjusted EPS $1.33, consensus $1.30 » 06:24
10/29/20
10/29
06:24
10/29/20
06:24
WLTW

Willis Towers Watson

$193.84 /

-6.49 (-3.24%)

Reports Q3 revenue $2.0B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WLTW Willis Towers Watson
$193.84 /

-6.49 (-3.24%)

WLTW Willis Towers Watson
$193.84 /

-6.49 (-3.24%)

10/06/20 Citi
Aon risk/reward 'compelling' across all deal scenarios, says Citi
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Raymond James
Raymond James downgrades Willis Towers Watson with focus on merger
08/05/20 Raymond James
Aon plc downgraded to Underperform from Market Perform at Raymond James
WLTW Willis Towers Watson
$193.84 /

-6.49 (-3.24%)

WLTW Willis Towers Watson
$193.84 /

-6.49 (-3.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.